Third-party candidates aim to disrupt Biden-Trump rematch in 2024
04:36
New drugs revolutionizing weight-loss and health care
04:34
Meta denies claim its business model maximizes kids’ screen time
05:15
Homebuyers spooked by rising interest rates, cooling market
04:16
Kevin McCarthy ousted as speaker: What happens next?
04:35
Immigration system under strain after latest surge at the border
04:34
Inside the manhunt of an escaped convict that captivated a nation
03:35
FDA expected to approve new COVID booster as cases rise in US
04:31
Homeowners face insurance woes amid rise in natural disasters
04:58
Maui locals face effort to rebuild three weeks after deadly wildfires
04:42
Tuohy family plans to end conservatorship of Michael Oher
04:33
What’s behind the increased shark sightings this summer?
04:42
Inside the economic power of Taylor Swift
05:00
Hollywood faces uncertain future amid SAG-AFTRA, WGA strikes
04:51
New health warnings after hottest days on Earth recorded
04:17
What’s next after Supreme Court’s college affirmative action ruling?
04:39
Adventure tourism scrutinized after Titanic submersible tragedy
04:39
Ozempic shakes up weight loss industry
04:53
Is wildfire smoke pollution in the U.S. a new reality?
04:15
Companies face backlash for LGBTQ support in online culture war
04:59
Experimental Alzheimer’s drug shows promising results in patients
04:38
Copied
Copied
An experimental drug for Alzheimer's was found to reduce cognitive decline in patients significantly, offering a potential breakthrough against the devastating disease. NBC’s Maggie Vespa reports in this week’s Sunday Focus on the risks and how soon the drug might be available.Dec. 4, 2022
